▶ 調査レポート

世界のメトトレキサート経口液剤市場 2021：企業別、地域別、種類・用途別
• 英文タイトル：Global Methotrexate Oral Solution Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026

GlobalInfoResearchが調査・発行した産業分析レポートです。世界のメトトレキサート経口液剤市場 2021：企業別、地域別、種類・用途別 / Global Methotrexate Oral Solution Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026 / GIR-2104Z09220資料のイメージです。• レポートコード：GIR-2104Z09220
• 出版社/出版日：GlobalInfoResearch / 2021年4月
※2025年版があります。お問い合わせください。
• レポート形態：英文、PDF、107ページ
• 納品方法：Eメール（納期：2~3日）
• 産業分類：医療・医薬品
• 販売価格（消費税別）
  Single User￥487,200 (USD3,480)▷ お問い合わせ
  Multi User￥730,800 (USD5,220)▷ お問い合わせ
  Corporate User￥974,400 (USD6,960)▷ お問い合わせ
• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
当調査資料では、メトトレキサート経口液剤のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。メトトレキサート経口液剤の種類別市場規模（2.5mg/ml、2mg/ml）、用途別市場規模（がん、自己免疫疾患、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。
・メトトレキサート経口液剤の市場概要
・企業情報（企業概要、製品概要、販売量、価格、売上）：Silvergate Pharmaceuticals
・企業別市場シェア
・地域別市場分析2016年-2026年
・種類別分析2016年-2026年：2.5mg/ml、2mg/ml
・用途別分析2016年-2026年：がん、自己免疫疾患、その他
・メトトレキサート経口液剤の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ
・メトトレキサート経口液剤のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア
・メトトレキサート経口液剤のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア
・メトトレキサート経口液剤の南米市場規模2016年-2026年：ブラジル、アルゼンチン
・メトトレキサート経口液剤の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

The Methotrexate Oral Solution market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Methotrexate Oral Solution size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Methotrexate Oral Solution market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Methotrexate Oral Solution market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
2.5mg/ml
2mg/ml

Market segment by Application can be divided into
Cancer
Autoimmune Diseases
Other

The key market players for global Methotrexate Oral Solution market are listed below:
Silvergate Pharmaceuticals

Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)

レポート目次

1 Market Overview
1.1 Methotrexate Oral Solution Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Methotrexate Oral Solution Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 2.5mg/ml
1.2.3 2mg/ml
1.3 Market Analysis by Application
1.3.1 Overview: Global Methotrexate Oral Solution Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Cancer
1.3.3 Autoimmune Diseases
1.3.4 Other
1.4 Global Methotrexate Oral Solution Market Size & Forecast
1.4.1 Global Methotrexate Oral Solution Sales in Value (2016-2026))
1.4.2 Global Methotrexate Oral Solution Sales in Volume (2016-2026)
1.4.3 Global Methotrexate Oral Solution Price by Type (2016-2026) & (USD/Unit)
1.5 Global Methotrexate Oral Solution Production Capacity Analysis
1.5.1 Global Methotrexate Oral Solution Total Production Capacity (2016-2026)
1.5.2 Global Methotrexate Oral Solution Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Methotrexate Oral Solution Market Drivers
1.6.2 Methotrexate Oral Solution Market Restraints
1.6.3 Methotrexate Oral Solution Trends Analysis
2 Manufacturers Profiles
2.1 Silvergate Pharmaceuticals
2.1.1 Silvergate Pharmaceuticals Details
2.1.2 Silvergate Pharmaceuticals Major Business
2.1.3 Silvergate Pharmaceuticals Methotrexate Oral Solution Product and Services
2.1.4 Silvergate Pharmaceuticals Methotrexate Oral Solution Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Methotrexate Oral Solution Sales by Manufacturer
3.1 Global Methotrexate Oral Solution Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Methotrexate Oral Solution Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Methotrexate Oral Solution
3.4 Market Concentration Rate
3.4.1 Top 3 Methotrexate Oral Solution Manufacturer Market Share
3.4.2 Top 6 Methotrexate Oral Solution Manufacturer Market Share
3.5 Global Methotrexate Oral Solution Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Methotrexate Oral Solution Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Methotrexate Oral Solution Market Size by Region
4.1.1 Global Methotrexate Oral Solution Sales in Volume by Region (2016-2026)
4.1.2 Global Methotrexate Oral Solution Revenue by Region (2016-2026)
4.2 North America Methotrexate Oral Solution Revenue (2016-2026)
4.3 Europe Methotrexate Oral Solution Revenue (2016-2026)
4.4 Asia-Pacific Methotrexate Oral Solution Revenue (2016-2026)
4.5 South America Methotrexate Oral Solution Revenue (2016-2026)
4.6 Middle East and Africa Methotrexate Oral Solution Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Methotrexate Oral Solution Sales in Volume by Type (2016-2026)
5.2 Global Methotrexate Oral Solution Revenue by Type (2016-2026)
5.3 Global Methotrexate Oral Solution Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Methotrexate Oral Solution Sales in Volume by Application (2016-2026)
6.2 Global Methotrexate Oral Solution Revenue by Application (2016-2026)
6.3 Global Methotrexate Oral Solution Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Methotrexate Oral Solution Sales by Type (2016-2026)
7.2 North America Methotrexate Oral Solution Sales by Application (2016-2026)
7.3 North America Methotrexate Oral Solution Market Size by Country
7.3.1 North America Methotrexate Oral Solution Sales in Volume by Country (2016-2026)
7.3.2 North America Methotrexate Oral Solution Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Methotrexate Oral Solution Sales by Type (2016-2026)
8.2 Europe Methotrexate Oral Solution Sales by Application (2016-2026)
8.3 Europe Methotrexate Oral Solution Market Size by Country
8.3.1 Europe Methotrexate Oral Solution Sales in Volume by Country (2016-2026)
8.3.2 Europe Methotrexate Oral Solution Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Methotrexate Oral Solution Sales by Type (2016-2026)
9.2 Asia-Pacific Methotrexate Oral Solution Sales by Application (2016-2026)
9.3 Asia-Pacific Methotrexate Oral Solution Market Size by Region
9.3.1 Asia-Pacific Methotrexate Oral Solution Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Methotrexate Oral Solution Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Methotrexate Oral Solution Sales by Type (2016-2026)
10.2 South America Methotrexate Oral Solution Sales by Application (2016-2026)
10.3 South America Methotrexate Oral Solution Market Size by Country
10.3.1 South America Methotrexate Oral Solution Sales in Volume by Country (2016-2026)
10.3.2 South America Methotrexate Oral Solution Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Methotrexate Oral Solution Sales by Type (2016-2026)
11.2 Middle East & Africa Methotrexate Oral Solution Sales by Application (2016-2026)
11.3 Middle East & Africa Methotrexate Oral Solution Market Size by Country
11.3.1 Middle East & Africa Methotrexate Oral Solution Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Methotrexate Oral Solution Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Methotrexate Oral Solution Typical Distributors
12.3 Methotrexate Oral Solution Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

List of Tables
Table 1. Global Methotrexate Oral Solution Revenue by Type, (USD Million), 2021-2026
Table 2. Global Methotrexate Oral Solution Revenue by Application, (USD Million), 2021-2026
Table 3. Silvergate Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 4. Silvergate Pharmaceuticals Major Business
Table 5. Silvergate Pharmaceuticals Methotrexate Oral Solution Product and Services
Table 6. Silvergate Pharmaceuticals Methotrexate Oral Solution Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Global Methotrexate Oral Solution Sales by Manufacturer (2019-2021e) & (K Units)
Table 8. Global Methotrexate Oral Solution Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 9. Market Position of Manufacturers in Methotrexate Oral Solution, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 10. Global Methotrexate Oral Solution Production Capacity by Company, (K Units): 2020 VS 2021
Table 11. Head Office and Methotrexate Oral Solution Production Site of Key Manufacturer
Table 12. Global Methotrexate Oral Solution Sales by Region (2016-2021e) & (K Units)
Table 13. Global Methotrexate Oral Solution Sales by Region (2021-2026) & (K Units)
Table 14. Global Methotrexate Oral Solution Revenue by Region (2016-2021e) & (USD Million)
Table 15. Global Methotrexate Oral Solution Revenue by Region (2021-2026) & (USD Million)
Table 16. Global Methotrexate Oral Solution Sales by Type (2016-2021e) & (K Units)
Table 17. Global Methotrexate Oral Solution Sales by Type (2021-2026) & (K Units)
Table 18. Global Methotrexate Oral Solution Revenue by Type (2016-2021e) & (USD Million)
Table 19. Global Methotrexate Oral Solution Revenue by Type (2021-2026) & (USD Million)
Table 20. Global Methotrexate Oral Solution Price by Type (2016-2021e) & (USD/Unit)
Table 21. Global Methotrexate Oral Solution Price by Type (2021-2026) & (USD/Unit)
Table 22. Global Methotrexate Oral Solution Sales by Application (2016-2021e) & (K Units)
Table 23. Global Methotrexate Oral Solution Sales by Application (2021-2026) & (K Units)
Table 24. Global Methotrexate Oral Solution Revenue by Application (2016-2021e) & (USD Million)
Table 25. Global Methotrexate Oral Solution Revenue by Application (2021-2026) & (USD Million)
Table 26. Global Methotrexate Oral Solution Price by Application (2016-2021e) & (USD/Unit)
Table 27. Global Methotrexate Oral Solution Price by Application (2021-2026) & (USD/Unit)
Table 28. North America Methotrexate Oral Solution Sales by Country (2016-2021e) & (K Units)
Table 29. North America Methotrexate Oral Solution Sales by Country (2021-2026) & (K Units)
Table 30. North America Methotrexate Oral Solution Revenue by Country (2016-2021e) & (USD Million)
Table 31. North America Methotrexate Oral Solution Revenue by Country (2021-2026) & (USD Million)
Table 32. North America Methotrexate Oral Solution Sales by Type (2016-2021e) & (K Units)
Table 33. North America Methotrexate Oral Solution Sales by Type (2021-2026) & (K Units)
Table 34. North America Methotrexate Oral Solution Sales by Application (2016-2021e) & (K Units)
Table 35. North America Methotrexate Oral Solution Sales by Application (2021-2026) & (K Units)
Table 36. Europe Methotrexate Oral Solution Sales by Country (2016-2021e) & (K Units)
Table 37. Europe Methotrexate Oral Solution Sales by Country (2021-2026) & (K Units)
Table 38. Europe Methotrexate Oral Solution Revenue by Country (2016-2021e) & (USD Million)
Table 39. Europe Methotrexate Oral Solution Revenue by Country (2021-2026) & (USD Million)
Table 40. Europe Methotrexate Oral Solution Sales by Type (2016-2021e) & (K Units)
Table 41. Europe Methotrexate Oral Solution Sales by Type (2021-2026) & (K Units)
Table 42. Europe Methotrexate Oral Solution Sales by Application (2016-2021e) & (K Units)
Table 43. Europe Methotrexate Oral Solution Sales by Application (2021-2026) & (K Units)
Table 44. Asia-Pacific Methotrexate Oral Solution Sales by Region (2016-2021e) & (K Units)
Table 45. Asia-Pacific Methotrexate Oral Solution Sales by Region (2021-2026) & (K Units)
Table 46. Asia-Pacific Methotrexate Oral Solution Revenue by Region (2016-2021e) & (USD Million)
Table 47. Asia-Pacific Methotrexate Oral Solution Revenue by Region (2021-2026) & (USD Million)
Table 48. Asia-Pacific Methotrexate Oral Solution Sales by Type (2016-2021e) & (K Units)
Table 49. Asia-Pacific Methotrexate Oral Solution Sales by Type (2021-2026) & (K Units)
Table 50. Asia-Pacific Methotrexate Oral Solution Sales by Application (2016-2021e) & (K Units)
Table 51. Asia-Pacific Methotrexate Oral Solution Sales by Application (2021-2026) & (K Units)
Table 52. South America Methotrexate Oral Solution Sales by Country (2016-2021e) & (K Units)
Table 53. South America Methotrexate Oral Solution Sales by Country (2021-2026) & (K Units)
Table 54. South America Methotrexate Oral Solution Revenue by Country (2016-2021e) & (USD Million)
Table 55. South America Methotrexate Oral Solution Revenue by Country (2021-2026) & (USD Million)
Table 56. South America Methotrexate Oral Solution Sales by Type (2016-2021e) & (K Units)
Table 57. South America Methotrexate Oral Solution Sales by Type (2021-2026) & (K Units)
Table 58. South America Methotrexate Oral Solution Sales by Application (2016-2021e) & (K Units)
Table 59. South America Methotrexate Oral Solution Sales by Application (2021-2026) & (K Units)
Table 60. Middle East & Africa Methotrexate Oral Solution Sales by Country (2016-2021e) & (K Units)
Table 61. Middle East & Africa Methotrexate Oral Solution Sales by Country (2021-2026) & (K Units)
Table 62. Middle East & Africa Methotrexate Oral Solution Revenue by Country (2016-2021e) & (USD Million)
Table 63. Middle East & Africa Methotrexate Oral Solution Revenue by Country (2021-2026) & (USD Million)
Table 64. Middle East & Africa Methotrexate Oral Solution Sales by Type (2016-2021e) & (K Units)
Table 65. Middle East & Africa Methotrexate Oral Solution Sales by Type (2021-2026) & (K Units)
Table 66. Middle East & Africa Methotrexate Oral Solution Sales by Application (2016-2021e) & (K Units)
Table 67. Middle East & Africa Methotrexate Oral Solution Sales by Application (2021-2026) & (K Units)
Table 68. Direct Channel Pros & Cons
Table 69. Indirect Channel Pros & Cons
Table 70. Methotrexate Oral Solution Typical Distributors
Table 71. Methotrexate Oral Solution Typical Customers
List of Figures
Figure 1. Methotrexate Oral Solution Picture
Figure 2. Global Methotrexate Oral Solution Sales Market Share by Type in 2020
Figure 3. 2.5mg/ml
Figure 4. 2mg/ml
Figure 5. Global Methotrexate Oral Solution Sales Market Share by Application in 2020
Figure 6. Cancer
Figure 7. Autoimmune Diseases
Figure 8. Other
Figure 9. Global Methotrexate Oral Solution Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 10. Global Methotrexate Oral Solution Market Size and Forecast (2016-2026) & (USD Million)
Figure 11. United States Methotrexate Oral Solution Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 12. Canada Methotrexate Oral Solution Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 13. Mexico Methotrexate Oral Solution Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. Germany Methotrexate Oral Solution Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. France Methotrexate Oral Solution Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. United Kingdom Methotrexate Oral Solution Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. Russia Methotrexate Oral Solution Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. Italy Methotrexate Oral Solution Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. China Methotrexate Oral Solution Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Japan Methotrexate Oral Solution Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. Korea Methotrexate Oral Solution Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. India Methotrexate Oral Solution Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Southeast Asia Methotrexate Oral Solution Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Australia Methotrexate Oral Solution Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Brazil Methotrexate Oral Solution Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Egypt Methotrexate Oral Solution Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Saudi Arabia Methotrexate Oral Solution Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. South Africa Methotrexate Oral Solution Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Turkey Methotrexate Oral Solution Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Global Methotrexate Oral Solution Sales (2016-2026) & (K Units)
Figure 31. Global Methotrexate Oral Solution Production Capacity (2016-2026) & (K Units)
Figure 32. Global Methotrexate Oral Solution Production Capacity by Geographic Region: 2020 VS 2021
Figure 33. Methotrexate Oral Solution Market Drivers
Figure 34. Methotrexate Oral Solution Market Restraints
Figure 35. Methotrexate Oral Solution Market Trends
Figure 36. Global Methotrexate Oral Solution Sales Market Share by Manufacturer in 2020
Figure 37. Global Methotrexate Oral Solution Revenue Market Share by Manufacturer in 2020
Figure 38. Methotrexate Oral Solution Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 39. Top 3 Methotrexate Oral Solution Manufacturer (Revenue) Market Share in 2020
Figure 40. Top 6 Methotrexate Oral Solution Manufacturer (Revenue) Market Share in 2020
Figure 41. Global Methotrexate Oral Solution Sales Market Share by Region (2016-2026)
Figure 42. Global Methotrexate Oral Solution Revenue Market Share by Region (2016-2026)
Figure 43. North America Methotrexate Oral Solution Revenue (2016-2026) & (USD Million)
Figure 44. Europe Methotrexate Oral Solution Revenue (2016-2026) & (USD Million)
Figure 45. Asia-Pacific Methotrexate Oral Solution Revenue (2016-2026) & (USD Million)
Figure 46. South America Methotrexate Oral Solution Revenue (2016-2026) & (USD Million)
Figure 47. Middle East & Africa Methotrexate Oral Solution Revenue (2016-2026) & (USD Million)
Figure 48. Global Methotrexate Oral Solution Sales Market Share by Type (2016-2026)
Figure 49. Global Methotrexate Oral Solution Revenue Market Share by Type (2016-2026)
Figure 50. Global Methotrexate Oral Solution Price by Type (2016-2026) & (USD/Unit)
Figure 51. Global Methotrexate Oral Solution Sales Market Share by Application (2016-2026)
Figure 52. Global Methotrexate Oral Solution Revenue Market Share by Application (2016-2026)
Figure 53. Global Methotrexate Oral Solution Price by Application (2016-2026) & (USD/Unit)
Figure 54. North America Methotrexate Oral Solution Sales Market Share by Country (2016-2026)
Figure 55. North America Methotrexate Oral Solution Revenue Market Share by Country (2016-2026)
Figure 56. North America Methotrexate Oral Solution Sales Market Share by Type (2016-2026)
Figure 57. North America Methotrexate Oral Solution Sales Market Share by Application (2016-2026)
Figure 58. Europe Methotrexate Oral Solution Sales Market Share by Country (2016-2026)
Figure 59. Europe Methotrexate Oral Solution Revenue Market Share by Country (2016-2026)
Figure 60. Europe Methotrexate Oral Solution Sales Market Share by Type (2016-2026)
Figure 61. Europe Methotrexate Oral Solution Sales Market Share by Application (2016-2026)
Figure 62. Asia-Pacific Methotrexate Oral Solution Sales Market Share by Region (2016-2026)
Figure 63. Asia-Pacific Methotrexate Oral Solution Revenue Market Share by Region (2016-2026)
Figure 64. Asia-Pacific Methotrexate Oral Solution Sales Market Share by Region (2016-2026)
Figure 65. Asia-Pacific Methotrexate Oral Solution Sales Market Share by Application (2016-2026)
Figure 66. South America Methotrexate Oral Solution Sales Market Share by Country (2016-2026)
Figure 67. South America Methotrexate Oral Solution Revenue Market Share by Country (2016-2026)
Figure 68. South America Methotrexate Oral Solution Sales Market Share by Type (2016-2026)
Figure 69. South America Methotrexate Oral Solution Sales Market Share by Application (2016-2026)
Figure 70. Middle East & Africa Methotrexate Oral Solution Sales Market Share by Country (2016-2026)
Figure 71. Middle East & Africa Methotrexate Oral Solution Revenue Market Share by Country (2016-2026)
Figure 72. Middle East & Africa Methotrexate Oral Solution Sales Market Share by Type (2016-2026)
Figure 73. Middle East & Africa Methotrexate Oral Solution Sales Market Share by Application (2016-2026)
Figure 74. Sales Channel: Direct Channel vs Indirect Channel
Figure 75. Methodology
Figure 76. Research Process and Data Source

以下、関連資料のご紹介
  • 世界のメトトレキサート経口液剤市場 2021：企業別、地域別、種類・用途別
    Global Methotrexate Oral Solution Drugs Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
    GIR-2104Z09221 2021年4月 108Pages
    当調査資料では、メトトレキサート経口液剤のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。メトトレキサート経口液剤の種類別市場規模（2.5mg/ml、2mg/ml）、用途別市場規模（がん、自己免疫疾患、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ...
  • 世界のメトトレキサート薬市場 2021：企業別、地域別、種類・用途別
    Global Methotrexate Drugs Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
    GIR-2104Z09219 2021年4月 102Pages
    当調査資料では、メトトレキサート薬のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。メトトレキサート薬の種類別市場規模（2.5mg/ml、2mg/ml）、用途別市場規模（がん、自己免疫疾患、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中...
  • 世界のメトトレキサートナトリウム市場 2021：企業別、地域別、種類・用途別
    Global Methotrexate Sodium Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
    GIR-2104Z09222 2021年4月 100Pages
    当調査資料では、メトトレキサートナトリウムのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。メトトレキサートナトリウムの種類別市場規模（メトトレキサートナトリウム錠、メトトレキサートナトリウム溶液）、用途別市場規模（経口、注射）、地域別市場規模（北米、ア...
  • 世界のメルカプトプリン経口液剤市場 2021：企業別、地域別、種類・用途別
    Global Mercaptopurine Oral Solution Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
    GIR-2104Z09114 2021年4月 100Pages
    当調査資料では、メルカプトプリン経口液剤のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。メルカプトプリン経口液剤の種類別市場規模（20mg/ml、5mg/ml）、用途別市場規模（病院、薬局）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日...
  • 世界のメルカプトプリン経口液剤市場 2021：企業別、地域別、種類・用途別
    Global Mercaptopurine Oral Solution Drugs Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
    GIR-2104Z09115 2021年4月 100Pages
    当調査資料では、メルカプトプリン経口液剤のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。メルカプトプリン経口液剤の種類別市場規模（20mg/ml、5mg/ml）、用途別市場規模（病院、薬局）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日...
  • 世界の経口コレラワクチン市場 2021：企業別、地域別、種類・用途別
    Global Oral Cholera Vaccine Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
    GIR-2104Z10297 2021年4月 107Pages
    当調査資料では、経口コレラワクチンのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。経口コレラワクチンの種類別市場規模（Shanchol、Dukoral、Vaxchora、その他）、用途別市場規模（病院、研究所＆学術研究所、製薬・バイオテクノロジー企業、...
  • 世界のコレラワクチン（経口用）市場 2021：企業別、地域別、種類・用途別
    Global Cholera Vaccine (Oral Route) Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
    GIR-2104Z03142 2021年4月 101Pages
    当調査資料では、コレラワクチン（経口用）のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。コレラワクチン（経口用）の種類別市場規模（Shanchol、Dukoral、Vaxchora、その他）、用途別市場規模（病院、研究所、製薬・バイオテクノロジー企業、...
  • 世界の経口用リバスチグミン市場 2021：企業別、地域別、種類・用途別
    Global Rivastigmine Oral Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
    GIR-2104Z12020 2021年4月 106Pages
    当調査資料では、経口用リバスチグミンのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。経口用リバスチグミンの種類別市場規模（1.5mgカプセル、3mgカプセル、4.5mgカプセル、6mgカプセル、2mg/ml経口液剤）、用途別市場規模（アルツハイマー病、...
  • 世界の経口糖尿病治療薬市場 2021：企業別、地域別、種類・用途別
    Global Oral Antidiabetic Drugs Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
    GIR-2104Z10291 2021年4月 105Pages
    当調査資料では、経口糖尿病治療薬のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。経口糖尿病治療薬の種類別市場規模（スルホニル尿素剤、メグリチニド、α-グルコシダーゼ阻害剤）、用途別市場規模（病院、診療所、その他）、地域別市場規模（北米、アメリカ、ヨーロ...
  • 世界の犬用経口咀嚼錠市場 2021：企業別、地域別、種類・用途別
    Global Canine Oral Chewable Tablets Market 2021 by Manufacturers, Regions, Type and Application, Forecast to 2026
    GIR-2104Z02689 2021年4月 107Pages
    当調査資料では、犬用経口咀嚼錠のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。犬用経口咀嚼錠の種類別市場規模（植物合成、化学合成）、用途別市場規模（獣医クリニック、獣医薬局、オンライン獣医店、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア...